Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends

BACKGROUND: Non-Vitamin K antagonist oral anticoagulants (NOACs) emerged as an alternative with comparable or superior efficacy and safety to vitamin K antagonists (VKAs) for stroke prevention in patients with non-valvular atrial fibrillation (AF). OBJECTIVES: The aim of the current study was to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiyovich, Arthur, Shalev, Varda, Chodick, Gabriel, Tirosh, Matanya, Katz, Amos, Klar, Miriam M., Shuvy, Mony, Pereg, David, Minha, Sa’ar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513259/
https://www.ncbi.nlm.nih.gov/pubmed/34645389
http://dx.doi.org/10.1186/s12872-021-02295-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513259/
https://www.ncbi.nlm.nih.gov/pubmed/34645389
http://dx.doi.org/10.1186/s12872-021-02295-w

Ejemplares similares